Jolkinolide A TN4356
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Jolkinolide A has anti-tumor activity. It inhibited VEGF expression in A549 cells through the inhibition of the Akt-STAT3-mTOR signaling pathway, and directly inhibited the proliferation and migration of HUVECs.
CAS nr:
37905-07-0
Purity:
98%
Molecular Weight:
314,4
SMILES:
CC1=C2[C@H]3O[C@]33CC[C@@H]4C(C)(C)CCC[C@@]4(C)[C@@H]3C=C2OC1=O
Formula:
C20H26O3
Pathway:
PI3K/Akt/mTOR signaling,Stem Cells,JAK/STAT signaling,Cytoskeletal Signaling,PI3K/Akt/mTOR signaling
Target:
mTOR,STAT,STAT,Akt,Akt
